David Brousseau, MD, MS

Professor of Pediatrics; Chief, Section of Pediatric Emergency Medicine

Locations

Children's Wisconsin, Emergency/Trauma
9000 W. Wisconsin Ave., Milwaukee, WI 53226

Education

MD, University of Virginia, 1989
MS, Brown University
Residency, Pediatrics, University of Colorado, 1996
Fellowship, Pediatric Emergency Medicine, Brown University, 2000

Research Interests

Dr. Brousseau is a clinical researcher, with a focus on emergency department/healthcare utilization. His recent research has focused on children with sickle cell disease, including efforts to improve the timeliness of emergency department care, better understanding risk factors for severe complications of sickle cell disease and use of healthcare resources for sickle cell disease. He has received multiple NIH grants, including an ongoing study through the Pediatric Emergency Care Applied Research Network (PECARN) assessing guideline adherent care for timeliness of emergency department pain treatment for children with sickle cell disease.

In addition to his own research, he focuses on research development of both trainees and faculty. He is the Director of the Medical College of Wisconsin TL1 training program and the Director of Scholarly Activities for the Medical College of Wisconsin. Dr. Brousseau has mentored junior and mid‐level faculty to successful grant funding in diverse areas including: healthcare utilization after NICU discharge, pain treatment for long bone fractures and de‐labelling of children with parent reported antibiotic allergies.

Assessment of pediatric asthma exacerbation with the use of new PROMIS measures.

(Nelson A, Ashima, Singh, Dasgupta M, Simpson PM, Chiu A, Brousseau DC, Panepinto JA.) J Asthma. 2021 Oct;58(10):1298-1306 PMID: 32576073 PMCID: PMC7794085 SCOPUS ID: 2-s2.0-85087818963 06/25/2020
Anaphylaxis knowledge gaps and future research priorities: A consensus report.

(Dribin TE, Schnadower D, Wang J, Camargo CA Jr, Michelson KA, Shaker M, Rudders SA, Vyles D, Golden DBK, Spergel JM, Campbell RL, Neuman MI, Capucilli PS, Pistiner M, Castells M, Lee J, Brousseau DC, Schneider LC, Assa'ad AH, Risma KA, Mistry RD, Campbell DE, Worm M, Turner PJ, Witry JK, Zhang Y, Sobolewski B, Sampson HA.) J Allergy Clin Immunol. 2021 Aug 12 PMID: 34390722 08/15/2021
Cephalosporin allergy symptoms in children presenting to a pediatric emergency department.

(Zembles T, Zhan Y, Chiu A, Brousseau DC, Vyles D.) Ann Allergy Asthma Immunol. 2021 08;127(2):259-260 PMID: 33940168 SCOPUS ID: 2-s2.0-85107440967 05/04/2021
Heart Disease, Advanced Age, Minority Race, and Hispanic Ethnicity Are Associated With Mortality in COVID-19 Patients.

(Conway BJ, Kim JW, Brousseau DC, Conroy M.) WMJ. 2021 Jul;120(2):152-155 PMID: 34255958 07/14/2021
Actual and Potential Impact of a Home Nasogastric Tube Feeding Program for Infants Whose Neonatal Intensive Care Unit Discharge Is Affected by Delayed Oral Feedings.

(Lagatta JM, Uhing M, Acharya K, Lavoie J, Rholl E, Malin K, Malnory M, Leuthner J, Brousseau DC.) J Pediatr. 2021 Jul;234:38-45.e2 PMID: 33789159 PMCID: PMC8238833 SCOPUS ID: 2-s2.0-85105322102 04/01/2021
Severity grading system for acute allergic reactions: A multidisciplinary Delphi study.

(Dribin TE, Schnadower D, Spergel JM, Campbell RL, Shaker M, Neuman MI, Michelson KA, Capucilli PS, Camargo CA Jr, Brousseau DC, Rudders SA, Assa'ad AH, Risma KA, Castells M, Schneider LC, Wang J, Lee J, Mistry RD, Vyles D, Pistiner M, Witry JK, Zhang Y, Sampson HA.) J Allergy Clin Immunol. 2021 Jul;148(1):173-181 PMID: 33476673 PMCID: PMC8273088 01/22/2021
PEMCRC anaphylaxis study protocol: a multicentre cohort study to derive and validate clinical decision models for the emergency department management of children with anaphylaxis.

(Dribin TE, Michelson KA, Vyles D, Neuman MI, Brousseau DC, Mistry RD, Dayan PS, Zhang N, Viswanathan S, Witry J, Boyd S, Schnadower D.) BMJ Open. 2021 01 05;11(1):e037341 PMID: 33402402 PMCID: PMC7786808 01/07/2021
Correlates of sexually transmitted infection testing following women's release from jail.

(Pickett ML, Lee J, Brousseau DC, Satterwhite C, Ramaswamy M.) Women Health. 2020 Nov-Dec;60(10):1109-1117 PMID: 32757716 PMCID: PMC7541798 SCOPUS ID: 2-s2.0-85089070643 08/08/2020
Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study.

(Dribin TE, Sampson HA, Camargo CA Jr, Brousseau DC, Spergel JM, Neuman MI, Shaker M, Campbell RL, Michelson KA, Rudders SA, Assa'ad AH, Risma KA, Castells M, Schneider LC, Wang J, Lee J, Mistry RD, Vyles D, Vaughn LM, Schumacher DJ, Witry JK, Viswanathan S, Page EM, Schnadower D.) J Allergy Clin Immunol. 2020 11;146(5):1089-1096 PMID: 32853640 PMCID: PMC8006564 08/28/2020
A Multiyear Cross-sectional Study of Guideline Adherence for the Timeliness of Opioid Administration in Children With Sickle Cell Pain Crisis.

(Brousseau DC, Alpern ER, Chamberlain JM, Ellison AM, Bajaj L, Cohen DM, Hariharan S, Cook LJ, Harding M, Panepinto J, Pediatric Emergency Care Applied Research Network (PECARN).) Ann Emerg Med. 2020 09;76(3S):S6-S11 PMID: 32928464 09/16/2020
The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain.

(Muslu CS, Kopetsky M, Nimmer M, Visotcky A, Fraser R, Brousseau DC.) Pediatr Blood Cancer. 2020 09;67(9):e28268 PMID: 32614150 PMCID: PMC7674235 SCOPUS ID: 2-s2.0-85087314028 07/03/2020
Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care.

(Brousseau DC, Muslu CS, Visotcky A, Fraser R, Kavanagh PL, Chelius TH, Schuh AM.) J Pediatr Hematol Oncol. 2020 08;42(6):412-413 PMID: 32404689 SCOPUS ID: 2-s2.0-85085583670 05/15/2020

Pediatric Emergency Medicine